Details
Johnson & Johnson Innovative Medicine is the pharmaceutical division of Johnson & Johnson, a global healthcare company focused on developing advanced medicines for serious and complex diseases. It is responsible for researching, developing, and commercialising prescription drugs across multiple therapeutic areas, including oncology, immunology, neuroscience, infectious diseases, and cardiovascular conditions. The division operates globally and works closely with healthcare providers, researchers, and regulatory bodies to bring new treatments to market.
The organisation is strongly research-driven, investing heavily in clinical trials and biomedical innovation. Its pipeline includes therapies such as immunotherapies, targeted cancer treatments, and biologic medicines designed to improve patient outcomes in areas where treatment options are limited. Johnson & Johnson Innovative Medicine also collaborates with academic institutions and biotech partners to accelerate drug discovery and improve the success rate of new therapies.
With a long history in healthcare innovation, the company is positioned as one of the leading players in the global pharmaceutical industry. It combines scientific research with advanced technology, including data science and AI, to shorten development timelines and improve precision in drug development while maintaining a strong focus on patient safety and regulatory standards.